• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

BioMarin settles with Elliott, adds 3 independent directors

cafead

Administrator
Staff member
  • cafead   Dec 21, 2023 at 10:02: AM
via BioMarin (BMRN.O) reached a settlement with activist investor Elliott Investment Management where the biotechnology company will add three independent directors to its board and form a committee to review operations.

article source
 

<